Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for ESRRA_ESR2
Z-value: 3.99
Motif logo
Transcription factors associated with ESRRA_ESR2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ESRRA
|
ENSG00000173153.9 | estrogen related receptor alpha |
|
ESR2
|
ENSG00000140009.14 | estrogen receptor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ESR2 | hg19_v2_chr14_-_64804814_64804842 | -0.28 | 1.2e-01 | Click! |
| ESRRA | hg19_v2_chr11_+_64073022_64073056 | 0.24 | 1.9e-01 | Click! |
Activity profile of ESRRA_ESR2 motif
Sorted Z-values of ESRRA_ESR2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_106174960 | 10.28 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
| chr1_-_173886491 | 9.71 |
ENST00000367698.3
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
| chr10_-_54531406 | 7.76 |
ENST00000373968.3
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble |
| chr22_+_22676808 | 7.64 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
| chr9_-_116840728 | 7.44 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
| chr22_+_23248512 | 7.01 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
| chr14_-_106322288 | 6.92 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr22_+_23237555 | 6.83 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
| chr14_-_106054659 | 6.76 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
| chr17_-_7082861 | 6.58 |
ENST00000269299.3
|
ASGR1
|
asialoglycoprotein receptor 1 |
| chr14_-_94857004 | 6.54 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr22_+_23243156 | 6.50 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
| chr14_-_94856987 | 6.18 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr22_+_23229960 | 6.08 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr14_-_94856951 | 6.06 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr4_-_155533787 | 5.91 |
ENST00000407946.1
ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG
|
fibrinogen gamma chain |
| chr3_-_52860850 | 5.74 |
ENST00000441637.2
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
| chr11_+_116700600 | 5.60 |
ENST00000227667.3
|
APOC3
|
apolipoprotein C-III |
| chr19_-_42133420 | 5.60 |
ENST00000221954.2
ENST00000600925.1 |
CEACAM4
|
carcinoembryonic antigen-related cell adhesion molecule 4 |
| chr14_-_106312010 | 5.57 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
| chr19_+_55105085 | 5.56 |
ENST00000251372.3
ENST00000453777.1 |
LILRA1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 |
| chr17_+_7533439 | 5.54 |
ENST00000441599.2
ENST00000380450.4 ENST00000416273.3 ENST00000575903.1 ENST00000576830.1 ENST00000571153.1 ENST00000575618.1 ENST00000576152.1 |
SHBG
|
sex hormone-binding globulin |
| chr14_-_106114739 | 5.52 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
| chr20_+_36974759 | 5.40 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
| chr16_-_29757272 | 5.39 |
ENST00000329410.3
|
C16orf54
|
chromosome 16 open reading frame 54 |
| chr22_+_23134974 | 5.38 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr14_-_106209368 | 5.38 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr11_+_116700614 | 5.34 |
ENST00000375345.1
|
APOC3
|
apolipoprotein C-III |
| chr1_-_207096529 | 5.34 |
ENST00000525793.1
ENST00000529560.1 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr7_-_87104963 | 5.31 |
ENST00000359206.3
ENST00000358400.3 ENST00000265723.4 |
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
| chr22_+_23247030 | 5.27 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr22_+_23089870 | 5.26 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr14_-_106642049 | 5.11 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr14_-_25078864 | 5.11 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
| chr11_-_116663127 | 5.10 |
ENST00000433069.1
ENST00000542499.1 |
APOA5
|
apolipoprotein A-V |
| chr19_+_42381173 | 5.07 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr1_-_205290865 | 5.06 |
ENST00000367157.3
|
NUAK2
|
NUAK family, SNF1-like kinase, 2 |
| chr3_+_52811596 | 5.01 |
ENST00000542827.1
ENST00000273283.2 |
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1 |
| chr11_-_118213360 | 5.00 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr20_+_62369623 | 5.00 |
ENST00000467211.1
|
RP4-583P15.14
|
RP4-583P15.14 |
| chr22_+_23264766 | 4.96 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr19_-_15590306 | 4.93 |
ENST00000292609.4
|
PGLYRP2
|
peptidoglycan recognition protein 2 |
| chr1_+_159557607 | 4.86 |
ENST00000255040.2
|
APCS
|
amyloid P component, serum |
| chr9_-_137809718 | 4.83 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
| chr14_+_22337014 | 4.78 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
| chr7_-_99381884 | 4.71 |
ENST00000336411.2
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
| chr3_-_58196939 | 4.67 |
ENST00000394549.2
ENST00000461914.3 |
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr11_-_118213331 | 4.49 |
ENST00000392884.2
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr14_-_107035208 | 4.49 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
| chr22_+_22385332 | 4.49 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr14_+_22204418 | 4.48 |
ENST00000390426.2
|
TRAV4
|
T cell receptor alpha variable 4 |
| chr7_-_100239132 | 4.48 |
ENST00000223051.3
ENST00000431692.1 |
TFR2
|
transferrin receptor 2 |
| chr3_-_52486841 | 4.46 |
ENST00000496590.1
|
TNNC1
|
troponin C type 1 (slow) |
| chr14_+_22475742 | 4.44 |
ENST00000390447.3
|
TRAV19
|
T cell receptor alpha variable 19 |
| chr19_+_18283959 | 4.43 |
ENST00000597802.2
|
IFI30
|
interferon, gamma-inducible protein 30 |
| chr1_+_209929494 | 4.41 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr14_-_106331652 | 4.31 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
| chr16_+_56995762 | 4.25 |
ENST00000200676.3
ENST00000379780.2 |
CETP
|
cholesteryl ester transfer protein, plasma |
| chr1_-_183538319 | 4.24 |
ENST00000420553.1
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
| chr6_-_167369612 | 4.23 |
ENST00000507747.1
|
RP11-514O12.4
|
RP11-514O12.4 |
| chr16_+_28996572 | 4.11 |
ENST00000360872.5
ENST00000566177.1 ENST00000354453.4 |
LAT
|
linker for activation of T cells |
| chr15_-_81616446 | 4.07 |
ENST00000302824.6
|
STARD5
|
StAR-related lipid transfer (START) domain containing 5 |
| chr7_-_150498426 | 4.07 |
ENST00000447204.2
|
TMEM176B
|
transmembrane protein 176B |
| chr8_+_22435762 | 4.05 |
ENST00000456545.1
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
| chr14_-_106330072 | 4.04 |
ENST00000488476.1
|
IGHJ5
|
immunoglobulin heavy joining 5 |
| chr8_-_131028660 | 3.99 |
ENST00000401979.2
ENST00000517654.1 ENST00000522361.1 ENST00000518167.1 |
FAM49B
|
family with sequence similarity 49, member B |
| chr12_+_6494285 | 3.96 |
ENST00000541102.1
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
| chr14_+_23016437 | 3.95 |
ENST00000478163.3
|
TRAC
|
T cell receptor alpha constant |
| chr11_-_116694009 | 3.95 |
ENST00000357780.3
|
APOA4
|
apolipoprotein A-IV |
| chr19_-_43032532 | 3.94 |
ENST00000403461.1
ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
| chr6_+_42883727 | 3.93 |
ENST00000304672.1
ENST00000441198.1 ENST00000446507.1 |
PTCRA
|
pre T-cell antigen receptor alpha |
| chr12_+_57849048 | 3.93 |
ENST00000266646.2
|
INHBE
|
inhibin, beta E |
| chr19_+_42300548 | 3.93 |
ENST00000344550.4
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
| chr2_+_85804614 | 3.91 |
ENST00000263864.5
ENST00000409760.1 |
VAMP8
|
vesicle-associated membrane protein 8 |
| chr6_+_31554962 | 3.88 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
| chr19_-_58864848 | 3.86 |
ENST00000263100.3
|
A1BG
|
alpha-1-B glycoprotein |
| chr6_+_31555045 | 3.86 |
ENST00000396101.3
ENST00000490742.1 |
LST1
|
leukocyte specific transcript 1 |
| chr1_-_169555779 | 3.83 |
ENST00000367797.3
ENST00000367796.3 |
F5
|
coagulation factor V (proaccelerin, labile factor) |
| chr22_+_35776828 | 3.83 |
ENST00000216117.8
|
HMOX1
|
heme oxygenase (decycling) 1 |
| chr22_+_44568825 | 3.83 |
ENST00000422871.1
|
PARVG
|
parvin, gamma |
| chr19_+_18284477 | 3.78 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
| chr8_-_134501873 | 3.76 |
ENST00000523634.1
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
| chr17_-_18945798 | 3.74 |
ENST00000395635.1
|
GRAP
|
GRB2-related adaptor protein |
| chr19_-_4540486 | 3.74 |
ENST00000306390.6
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1 |
| chr19_+_1065922 | 3.73 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr7_-_142232071 | 3.73 |
ENST00000390364.3
|
TRBV10-1
|
T cell receptor beta variable 10-1(gene/pseudogene) |
| chr14_-_106733624 | 3.68 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chr17_-_3595042 | 3.67 |
ENST00000552723.1
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
| chr19_-_54872556 | 3.65 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
| chr22_+_23029188 | 3.65 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr19_-_11688260 | 3.63 |
ENST00000590832.1
|
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr7_-_142198049 | 3.62 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
| chr17_+_77704681 | 3.62 |
ENST00000328313.5
|
ENPP7
|
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
| chr2_+_98330009 | 3.60 |
ENST00000264972.5
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa |
| chr22_+_50624323 | 3.58 |
ENST00000380909.4
ENST00000303434.4 |
TRABD
|
TraB domain containing |
| chr1_-_27240455 | 3.53 |
ENST00000254227.3
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2 |
| chr22_+_35776354 | 3.51 |
ENST00000412893.1
|
HMOX1
|
heme oxygenase (decycling) 1 |
| chr19_+_45251804 | 3.51 |
ENST00000164227.5
|
BCL3
|
B-cell CLL/lymphoma 3 |
| chr1_+_47603109 | 3.50 |
ENST00000371890.3
ENST00000294337.3 ENST00000371891.3 |
CYP4A22
|
cytochrome P450, family 4, subfamily A, polypeptide 22 |
| chr3_+_52812523 | 3.48 |
ENST00000540715.1
|
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1 |
| chr15_-_22473353 | 3.48 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
| chr2_-_89310012 | 3.48 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr8_-_134501937 | 3.46 |
ENST00000519924.1
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
| chr16_+_3115298 | 3.46 |
ENST00000325568.5
ENST00000534507.1 |
IL32
|
interleukin 32 |
| chr11_-_118083600 | 3.46 |
ENST00000524477.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
| chrX_-_47489244 | 3.44 |
ENST00000469388.1
ENST00000396992.3 ENST00000377005.2 |
CFP
|
complement factor properdin |
| chr4_-_40632140 | 3.44 |
ENST00000514782.1
|
RBM47
|
RNA binding motif protein 47 |
| chr17_-_5487277 | 3.43 |
ENST00000572272.1
ENST00000354411.3 ENST00000577119.1 |
NLRP1
|
NLR family, pyrin domain containing 1 |
| chr16_+_30194293 | 3.42 |
ENST00000561815.1
|
CORO1A
|
coronin, actin binding protein, 1A |
| chr19_+_42301079 | 3.42 |
ENST00000596544.1
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
| chr19_-_10450287 | 3.41 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
| chr4_-_71532601 | 3.41 |
ENST00000510614.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr16_+_28996416 | 3.41 |
ENST00000395456.2
ENST00000454369.2 |
LAT
|
linker for activation of T cells |
| chr22_+_23040274 | 3.39 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr2_-_89247338 | 3.39 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr3_-_49726104 | 3.39 |
ENST00000383728.3
ENST00000545762.1 |
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
| chr14_-_96180435 | 3.37 |
ENST00000556450.1
ENST00000555202.1 ENST00000554012.1 ENST00000402399.1 |
TCL1A
|
T-cell leukemia/lymphoma 1A |
| chr14_+_22689792 | 3.36 |
ENST00000390462.1
|
TRAV35
|
T cell receptor alpha variable 35 |
| chr22_+_22749343 | 3.34 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
| chr22_-_37545972 | 3.33 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
| chr19_+_1041212 | 3.32 |
ENST00000433129.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
| chr12_-_2027639 | 3.32 |
ENST00000586184.1
ENST00000587995.1 ENST00000585732.1 |
CACNA2D4
|
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
| chr1_+_158149737 | 3.30 |
ENST00000368171.3
|
CD1D
|
CD1d molecule |
| chr16_+_3115378 | 3.29 |
ENST00000529550.1
ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32
|
interleukin 32 |
| chr7_-_142162390 | 3.26 |
ENST00000390371.3
|
TRBV6-6
|
T cell receptor beta variable 6-6 |
| chr1_+_29213678 | 3.25 |
ENST00000347529.3
|
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
| chr19_-_10446449 | 3.24 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
| chr1_+_200842083 | 3.20 |
ENST00000304244.2
|
GPR25
|
G protein-coupled receptor 25 |
| chr15_+_91418918 | 3.18 |
ENST00000560824.1
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
| chr14_-_107095662 | 3.17 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
| chr19_+_42300369 | 3.17 |
ENST00000357396.3
ENST00000221999.4 |
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
| chr4_-_71532668 | 3.16 |
ENST00000510437.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr19_-_39108568 | 3.16 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr7_+_150026938 | 3.16 |
ENST00000343855.4
|
ZBED6CL
|
ZBED6 C-terminal like |
| chr8_+_67039278 | 3.16 |
ENST00000276573.7
ENST00000350034.4 |
TRIM55
|
tripartite motif containing 55 |
| chr2_-_89513402 | 3.16 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr9_+_139839711 | 3.15 |
ENST00000224181.3
|
C8G
|
complement component 8, gamma polypeptide |
| chr11_+_46740730 | 3.14 |
ENST00000311907.5
ENST00000530231.1 ENST00000442468.1 |
F2
|
coagulation factor II (thrombin) |
| chr13_-_46679144 | 3.14 |
ENST00000181383.4
|
CPB2
|
carboxypeptidase B2 (plasma) |
| chr20_+_31595406 | 3.13 |
ENST00000170150.3
|
BPIFB2
|
BPI fold containing family B, member 2 |
| chr2_-_89278535 | 3.13 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr7_-_38398721 | 3.12 |
ENST00000390346.2
|
TRGV3
|
T cell receptor gamma variable 3 |
| chr7_-_105926058 | 3.12 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr14_+_22446680 | 3.12 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
| chr22_+_22764088 | 3.11 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
| chr7_-_105925558 | 3.10 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr7_-_142099977 | 3.09 |
ENST00000390359.3
|
TRBV7-8
|
T cell receptor beta variable 7-8 |
| chr1_+_29213584 | 3.09 |
ENST00000343067.4
ENST00000356093.2 ENST00000398863.2 ENST00000373800.3 ENST00000349460.4 |
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
| chr11_-_73687997 | 3.08 |
ENST00000545212.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
| chr17_-_34345002 | 3.08 |
ENST00000293280.2
|
CCL23
|
chemokine (C-C motif) ligand 23 |
| chr16_+_30484054 | 3.08 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr7_+_99971129 | 3.07 |
ENST00000394000.2
ENST00000350573.2 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
| chr1_-_203151933 | 3.06 |
ENST00000404436.2
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39) |
| chr20_+_61584026 | 3.06 |
ENST00000370351.4
ENST00000370349.3 |
SLC17A9
|
solute carrier family 17 (vesicular nucleotide transporter), member 9 |
| chr1_-_235116495 | 3.06 |
ENST00000549744.1
|
RP11-443B7.3
|
RP11-443B7.3 |
| chr2_+_128175997 | 3.06 |
ENST00000234071.3
ENST00000429925.1 ENST00000442644.1 ENST00000453608.2 |
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa) |
| chr14_-_106453155 | 3.06 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr11_+_71846764 | 3.04 |
ENST00000456237.1
ENST00000442948.2 ENST00000546166.1 |
FOLR3
|
folate receptor 3 (gamma) |
| chr14_+_22409308 | 3.03 |
ENST00000390441.2
|
TRAV9-2
|
T cell receptor alpha variable 9-2 |
| chr16_+_3115323 | 3.01 |
ENST00000531965.1
ENST00000396887.3 ENST00000529699.1 ENST00000526464.2 ENST00000440815.3 |
IL32
|
interleukin 32 |
| chr2_+_219264466 | 3.01 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr12_-_122296755 | 3.01 |
ENST00000289004.4
|
HPD
|
4-hydroxyphenylpyruvate dioxygenase |
| chr19_-_2256405 | 3.01 |
ENST00000300961.6
|
JSRP1
|
junctional sarcoplasmic reticulum protein 1 |
| chr7_-_142131914 | 3.01 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
| chr13_-_46679185 | 3.00 |
ENST00000439329.3
|
CPB2
|
carboxypeptidase B2 (plasma) |
| chr9_+_139839686 | 3.00 |
ENST00000371634.2
|
C8G
|
complement component 8, gamma polypeptide |
| chr2_+_234627424 | 2.99 |
ENST00000373409.3
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4 |
| chr17_-_7080801 | 2.99 |
ENST00000572879.1
|
ASGR1
|
asialoglycoprotein receptor 1 |
| chr11_-_118213455 | 2.99 |
ENST00000300692.4
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr20_-_62203808 | 2.99 |
ENST00000467148.1
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
| chr10_+_81370689 | 2.99 |
ENST00000372308.3
ENST00000398636.3 ENST00000428376.2 ENST00000372313.5 ENST00000419470.2 ENST00000429958.1 ENST00000439264.1 |
SFTPA1
|
surfactant protein A1 |
| chr2_+_89986318 | 2.99 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
| chr22_+_22712087 | 2.99 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
| chr3_+_46538981 | 2.99 |
ENST00000296142.3
|
RTP3
|
receptor (chemosensory) transporter protein 3 |
| chr11_-_116662593 | 2.97 |
ENST00000227665.4
|
APOA5
|
apolipoprotein A-V |
| chr19_-_11689752 | 2.97 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr17_+_45810594 | 2.97 |
ENST00000177694.1
|
TBX21
|
T-box 21 |
| chr14_-_55369525 | 2.96 |
ENST00000543643.2
ENST00000536224.2 ENST00000395514.1 ENST00000491895.2 |
GCH1
|
GTP cyclohydrolase 1 |
| chr11_+_3876859 | 2.96 |
ENST00000300737.4
|
STIM1
|
stromal interaction molecule 1 |
| chr2_+_44066101 | 2.95 |
ENST00000272286.2
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
| chr3_+_128779610 | 2.95 |
ENST00000307395.4
|
GP9
|
glycoprotein IX (platelet) |
| chr22_-_42526802 | 2.95 |
ENST00000359033.4
ENST00000389970.3 ENST00000360608.5 |
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6 |
| chr11_+_67171391 | 2.94 |
ENST00000312390.5
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr17_-_64216748 | 2.94 |
ENST00000585162.1
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr19_-_39108643 | 2.94 |
ENST00000396857.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr2_+_218990727 | 2.93 |
ENST00000318507.2
ENST00000454148.1 |
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
| chr14_+_22591276 | 2.93 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
| chr2_+_208527094 | 2.93 |
ENST00000429730.1
|
AC079767.4
|
AC079767.4 |
| chr7_-_142120321 | 2.92 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
| chr14_-_106237742 | 2.92 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
| chr11_+_71846748 | 2.91 |
ENST00000445078.2
|
FOLR3
|
folate receptor 3 (gamma) |
| chr2_+_128177458 | 2.91 |
ENST00000409048.1
ENST00000422777.3 |
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa) |
| chr2_-_89442621 | 2.91 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr22_-_42828375 | 2.91 |
ENST00000329021.5
|
NFAM1
|
NFAT activating protein with ITAM motif 1 |
| chr1_-_111743285 | 2.90 |
ENST00000357640.4
|
DENND2D
|
DENN/MADD domain containing 2D |
| chr6_+_31554779 | 2.90 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
| chr1_-_169555709 | 2.90 |
ENST00000546081.1
|
F5
|
coagulation factor V (proaccelerin, labile factor) |
| chr3_-_58196688 | 2.90 |
ENST00000486455.1
|
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr21_-_46330545 | 2.88 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr16_+_30194118 | 2.88 |
ENST00000563778.1
|
CORO1A
|
coronin, actin binding protein, 1A |
Network of associatons between targets according to the STRING database.
First level regulatory network of ESRRA_ESR2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.4 | 13.1 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 2.9 | 2.9 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 2.7 | 18.8 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 2.7 | 8.0 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
| 2.5 | 9.9 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 2.4 | 12.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 2.4 | 2.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 2.2 | 4.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 2.2 | 24.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 2.2 | 6.6 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 2.1 | 6.3 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 2.1 | 2.1 | GO:0070254 | mucus secretion(GO:0070254) |
| 2.1 | 6.2 | GO:0071258 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 2.1 | 8.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 2.0 | 8.0 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 2.0 | 6.0 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 2.0 | 13.9 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 1.9 | 5.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 1.9 | 7.5 | GO:0002432 | granuloma formation(GO:0002432) |
| 1.9 | 9.3 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.8 | 7.3 | GO:0006788 | heme oxidation(GO:0006788) |
| 1.8 | 9.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 1.8 | 8.8 | GO:0032796 | uropod organization(GO:0032796) |
| 1.7 | 13.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.6 | 4.9 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 1.6 | 11.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 1.6 | 3.2 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.5 | 10.8 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 1.5 | 4.6 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 1.5 | 7.4 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
| 1.5 | 19.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 1.4 | 4.3 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 1.4 | 8.6 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.4 | 4.3 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 1.4 | 5.7 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 1.4 | 5.7 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 1.4 | 4.2 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 1.4 | 14.1 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 1.4 | 4.2 | GO:0002818 | intracellular defense response(GO:0002818) |
| 1.4 | 9.5 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 1.3 | 5.4 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 1.3 | 4.0 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 1.3 | 4.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 1.3 | 16.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 1.3 | 105.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 1.3 | 11.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.3 | 5.1 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 1.2 | 6.0 | GO:0032571 | response to vitamin K(GO:0032571) |
| 1.2 | 6.0 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 1.2 | 7.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 1.2 | 1.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 1.2 | 9.5 | GO:0046618 | drug export(GO:0046618) |
| 1.2 | 5.9 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 1.1 | 18.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 1.1 | 3.4 | GO:0002368 | B cell cytokine production(GO:0002368) |
| 1.1 | 6.7 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 1.1 | 1.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 1.1 | 4.4 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 1.1 | 3.3 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 1.1 | 3.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.1 | 7.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 1.1 | 16.3 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) |
| 1.1 | 6.5 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 1.1 | 2.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 1.1 | 7.5 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 1.1 | 3.2 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 1.1 | 3.2 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 1.1 | 4.2 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 1.0 | 5.1 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 1.0 | 2.0 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.0 | 3.0 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 1.0 | 1.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 1.0 | 1.0 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 1.0 | 4.8 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.0 | 2.9 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.9 | 4.7 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.9 | 3.8 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.9 | 3.8 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.9 | 0.9 | GO:0003162 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.9 | 2.8 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.9 | 3.7 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.9 | 2.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.9 | 4.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.9 | 4.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.9 | 2.7 | GO:0090346 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.9 | 1.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.9 | 3.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.9 | 3.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.9 | 4.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.9 | 10.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.9 | 95.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.9 | 6.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.9 | 32.1 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
| 0.9 | 6.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.9 | 5.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
| 0.9 | 3.4 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.9 | 0.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.8 | 3.4 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.8 | 5.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.8 | 1.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.8 | 7.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.8 | 2.4 | GO:0052251 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.8 | 0.8 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.8 | 6.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.8 | 4.8 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.8 | 2.4 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.8 | 2.4 | GO:0002352 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.8 | 0.8 | GO:1904640 | response to methionine(GO:1904640) |
| 0.8 | 3.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.8 | 6.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.8 | 2.3 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.8 | 1.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.8 | 3.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.8 | 1.5 | GO:1904044 | response to aldosterone(GO:1904044) |
| 0.8 | 7.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.8 | 1.5 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.8 | 2.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.8 | 3.0 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.8 | 5.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.8 | 6.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.7 | 2.2 | GO:0001878 | response to yeast(GO:0001878) |
| 0.7 | 3.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.7 | 5.9 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.7 | 1.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.7 | 2.2 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 0.7 | 10.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.7 | 5.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.7 | 2.2 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.7 | 4.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.7 | 9.5 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.7 | 2.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.7 | 3.6 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.7 | 2.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.7 | 2.1 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.7 | 0.7 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.7 | 0.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.7 | 7.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.7 | 4.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.7 | 2.8 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.7 | 2.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.7 | 2.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.7 | 0.7 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.7 | 2.7 | GO:0038185 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.7 | 8.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.7 | 6.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.7 | 3.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.7 | 4.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.7 | 2.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.7 | 2.0 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.7 | 0.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.7 | 1.3 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.7 | 2.0 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.7 | 2.0 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.6 | 1.3 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.6 | 1.9 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.6 | 13.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.6 | 2.6 | GO:0045589 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
| 0.6 | 1.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.6 | 3.2 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.6 | 0.6 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.6 | 9.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.6 | 3.8 | GO:0072679 | thymocyte migration(GO:0072679) |
| 0.6 | 1.9 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.6 | 2.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 2.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.6 | 5.0 | GO:0008228 | opsonization(GO:0008228) |
| 0.6 | 1.9 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.6 | 3.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.6 | 4.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.6 | 3.1 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.6 | 3.7 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
| 0.6 | 1.8 | GO:1904344 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 0.6 | 3.6 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.6 | 3.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.6 | 8.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.6 | 3.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.6 | 2.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.6 | 2.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.6 | 2.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 0.6 | 1.8 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.6 | 1.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.6 | 1.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.6 | 0.6 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.6 | 0.6 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 0.6 | 1.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.6 | 2.9 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.6 | 36.3 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.6 | 4.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.6 | 2.3 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.6 | 0.6 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
| 0.6 | 6.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.6 | 1.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.6 | 1.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.6 | 2.3 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.6 | 1.1 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.6 | 4.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.6 | 0.6 | GO:0060374 | mast cell differentiation(GO:0060374) |
| 0.6 | 0.6 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.6 | 1.7 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.6 | 2.2 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.6 | 2.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.6 | 6.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.6 | 0.6 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.6 | 1.7 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.6 | 6.1 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.6 | 1.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.6 | 1.7 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.6 | 1.1 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.6 | 0.6 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 0.5 | 1.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.5 | 2.2 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.5 | 1.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.5 | 7.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.5 | 2.7 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.5 | 2.7 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.5 | 2.7 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.5 | 3.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.5 | 1.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.5 | 1.1 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 0.5 | 2.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.5 | 1.6 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.5 | 1.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.5 | 2.6 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.5 | 2.1 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.5 | 1.6 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.5 | 1.5 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.5 | 2.6 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.5 | 0.5 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.5 | 5.6 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.5 | 0.5 | GO:0046878 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
| 0.5 | 5.6 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.5 | 0.5 | GO:0032620 | interleukin-17 production(GO:0032620) |
| 0.5 | 0.5 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.5 | 2.0 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.5 | 7.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.5 | 0.5 | GO:2000664 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.5 | 1.0 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.5 | 4.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.5 | 1.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.5 | 12.8 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.5 | 3.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.5 | 2.5 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
| 0.5 | 1.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.5 | 1.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.5 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
| 0.5 | 2.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.5 | 7.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 3.4 | GO:2000330 | positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
| 0.5 | 1.5 | GO:0002884 | negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
| 0.5 | 2.4 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.5 | 1.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.5 | 1.0 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.5 | 0.5 | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
| 0.5 | 3.4 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.5 | 4.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.5 | 2.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.5 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.5 | 2.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.5 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.5 | 88.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.5 | 4.2 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.5 | 6.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.5 | 0.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.5 | 1.4 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.5 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.5 | 0.5 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.5 | 1.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.5 | 7.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.5 | 1.4 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.5 | 0.9 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.5 | 2.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.5 | 2.3 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.5 | 1.4 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.5 | 1.4 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.5 | 2.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 | 0.9 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.5 | 1.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.5 | 0.9 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.5 | 2.3 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.5 | 0.5 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.5 | 1.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.5 | 1.4 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.4 | 4.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.4 | 0.9 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.4 | 12.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.4 | 13.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.4 | 0.4 | GO:0002554 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.4 | 1.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.4 | 2.6 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.4 | 1.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 | 1.8 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
| 0.4 | 0.9 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.4 | 4.4 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.4 | 7.0 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.4 | 3.9 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.4 | 1.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.4 | 1.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.4 | 1.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.4 | 0.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.4 | 4.3 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
| 0.4 | 3.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.4 | 1.3 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.4 | 2.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 0.9 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.4 | 1.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
| 0.4 | 0.9 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.4 | 0.9 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.4 | 26.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.4 | 0.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.4 | 1.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.4 | 3.0 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.4 | 1.7 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.4 | 2.5 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.4 | 2.9 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.4 | 3.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.4 | 1.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.4 | 0.4 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.4 | 1.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.4 | 2.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.4 | 3.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.4 | 4.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.4 | 0.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.4 | 3.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.4 | 4.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.4 | 4.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.4 | 2.8 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.4 | 0.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.4 | 0.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.4 | 5.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.4 | 1.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.4 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.4 | 0.4 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.4 | 1.6 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.4 | 4.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.4 | 1.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.4 | 4.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.4 | 0.8 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.4 | 0.8 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.4 | 0.4 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.4 | 2.0 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.4 | 2.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 | 1.2 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.4 | 1.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.4 | 1.2 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.4 | 3.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 | 0.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 0.8 | GO:0052314 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
| 0.4 | 1.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.4 | 7.7 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.4 | 1.1 | GO:0071106 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.4 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.4 | 0.8 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.4 | 1.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.4 | 1.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.4 | 35.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.4 | 12.0 | GO:0015893 | drug transport(GO:0015893) |
| 0.4 | 0.4 | GO:0009648 | photoperiodism(GO:0009648) |
| 0.4 | 5.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.4 | 1.5 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.4 | 1.5 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.4 | 1.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.4 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.4 | 2.2 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.4 | 1.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.4 | 1.1 | GO:0035573 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.4 | 0.7 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.4 | 1.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.4 | 0.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.4 | 1.5 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.4 | 1.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.4 | 3.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 0.4 | 1.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.4 | 5.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.4 | 0.7 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.4 | 1.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.4 | 2.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.4 | 9.7 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.4 | 1.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.4 | 0.7 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.4 | 9.6 | GO:0019835 | cytolysis(GO:0019835) |
| 0.4 | 0.4 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.4 | 6.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.4 | 1.8 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.4 | 0.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.4 | 0.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.4 | 0.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.4 | 1.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 | 6.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.3 | 4.1 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.3 | 14.4 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.3 | 7.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.3 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 1.7 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 | 1.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 1.0 | GO:1904247 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.3 | 1.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 1.7 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.3 | 2.3 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.3 | 1.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.3 | 3.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.3 | 0.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.3 | 1.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 | 21.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.3 | 0.7 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
| 0.3 | 0.3 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.3 | 1.0 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.3 | 5.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.3 | 1.0 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.3 | 5.5 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
| 0.3 | 1.9 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.3 | 1.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 | 1.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.3 | 5.7 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.3 | 2.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.3 | 1.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.3 | 2.5 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.3 | 1.6 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.3 | 1.9 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.3 | 3.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.3 | 0.9 | GO:0006066 | alcohol metabolic process(GO:0006066) |
| 0.3 | 86.2 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.3 | 1.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.3 | 0.6 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.3 | 1.3 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.3 | 2.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 4.1 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.3 | 3.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.3 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.3 | 1.2 | GO:1905044 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.3 | 3.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.3 | 0.6 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.3 | 0.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.3 | 1.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 | 1.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.3 | 1.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.3 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.3 | 6.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.3 | 0.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 0.3 | 2.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.3 | 0.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.3 | 1.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 | 0.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.3 | 2.1 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.3 | 5.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.3 | 3.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 | 0.9 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.3 | 0.6 | GO:0009624 | response to nematode(GO:0009624) |
| 0.3 | 0.9 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.3 | 3.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 | 0.6 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.3 | 1.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.3 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.3 | 0.9 | GO:0061419 | coronary vein morphogenesis(GO:0003169) cardiac vascular smooth muscle cell development(GO:0060948) positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.3 | 1.2 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.3 | 0.9 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.3 | 2.9 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.3 | 3.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 1.1 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.3 | 0.9 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.3 | 1.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.3 | 0.9 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.3 | 5.1 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.3 | 2.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 0.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.3 | 0.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 | 0.8 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.3 | 2.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.3 | 1.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 1.1 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.3 | 1.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.3 | 0.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.3 | 0.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.3 | 1.4 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.3 | 3.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.3 | 1.1 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.3 | 2.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 | 0.8 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.3 | 1.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.3 | 1.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.3 | 0.3 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 0.3 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.3 | 0.8 | GO:0070640 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
| 0.3 | 1.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 0.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.3 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.3 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.3 | 0.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.3 | 5.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.3 | 0.5 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.3 | 2.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.3 | 5.6 | GO:0051923 | sulfation(GO:0051923) |
| 0.3 | 1.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.3 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.3 | 16.3 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.3 | 3.4 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.3 | 0.3 | GO:0001768 | establishment of T cell polarity(GO:0001768) |
| 0.3 | 0.8 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.3 | 1.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.3 | 3.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.3 | 1.0 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.3 | 3.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 0.3 | 0.5 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.3 | 4.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.3 | 2.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 | 1.8 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.3 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.3 | 1.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.3 | 0.8 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.3 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.3 | 4.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.3 | 1.0 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.3 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.3 | 1.5 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.3 | 1.0 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.3 | 1.0 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.3 | 1.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.3 | 1.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 | 2.0 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.3 | 0.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.3 | 0.5 | GO:0071335 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) actin filament branching(GO:0090135) |
| 0.2 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.2 | 0.7 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.2 | 0.2 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 0.2 | 3.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 | 1.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 | 0.5 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.2 | 3.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 | 7.6 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.2 | 0.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.2 | 0.2 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.2 | 1.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.2 | 0.7 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.2 | 2.2 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 0.2 | GO:0010138 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
| 0.2 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.2 | 1.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 | 1.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.2 | 0.7 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.2 | 1.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.2 | 2.6 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.2 | 8.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.2 | 1.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 0.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 | 0.7 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
| 0.2 | 1.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.2 | 4.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.2 | 1.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 1.9 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.2 | 0.7 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.2 | 1.6 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.2 | 1.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.2 | 0.7 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.2 | 0.7 | GO:0001554 | luteolysis(GO:0001554) |
| 0.2 | 3.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 0.7 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.2 | 1.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 2.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 1.8 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 1.8 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.2 | 0.9 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
| 0.2 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 0.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.2 | 1.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.2 | 20.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 | 0.7 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) regulation of mitotic cell cycle DNA replication(GO:1903463) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.2 | 1.4 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.2 | 0.7 | GO:0002396 | MHC protein complex assembly(GO:0002396) |
| 0.2 | 0.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 | 0.4 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
| 0.2 | 0.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.2 | 0.9 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 0.9 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 4.0 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.2 | 0.7 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.2 | 3.1 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 1.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.2 | 2.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.2 | 1.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 2.0 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.2 | 0.4 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.2 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.2 | 0.7 | GO:0048627 | myoblast development(GO:0048627) |
| 0.2 | 0.2 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.2 | 0.6 | GO:0010193 | response to ozone(GO:0010193) |
| 0.2 | 0.4 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.2 | 1.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
| 0.2 | 0.4 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.2 | 1.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.2 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.2 | 1.7 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 3.4 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 2.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.2 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.2 | 2.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 | 2.3 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.2 | 3.8 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.2 | 2.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 2.3 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.2 | 0.4 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.2 | 1.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 | 0.8 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.2 | 4.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 | 2.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.2 | 0.4 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.2 | 0.8 | GO:2000403 | positive regulation of lymphocyte migration(GO:2000403) |
| 0.2 | 1.2 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.2 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 4.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.2 | 2.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 1.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 1.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 1.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.2 | 0.8 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.2 | 0.4 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.2 | 1.4 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 0.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 0.2 | 2.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 1.0 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 | 0.4 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.2 | 0.8 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 | 1.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 3.2 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 | 1.8 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.2 | 1.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 | 0.4 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 | 0.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.2 | 15.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.2 | 0.6 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 | 0.4 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.2 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 0.8 | GO:0046016 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) late viral transcription(GO:0019086) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.2 | 12.7 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.2 | 0.8 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 | 0.2 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 0.2 | 1.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.2 | 2.3 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.2 | 1.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.2 | 0.6 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.2 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 | 0.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 | 0.4 | GO:1903217 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.2 | 0.4 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.2 | 0.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 | 6.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.2 | 2.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) |
| 0.2 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.2 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 | 1.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.2 | 0.7 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.2 | 2.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 0.6 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 | 4.4 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
| 0.2 | 0.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.2 | 3.8 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.2 | 0.5 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.2 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.2 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.2 | 0.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.2 | 1.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.2 | 3.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.2 | 1.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.2 | 0.2 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 | 3.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.2 | 5.0 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.2 | 3.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 0.5 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.2 | 1.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.2 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 1.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 1.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.2 | 1.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.2 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.2 | 0.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.2 | 0.2 | GO:0001906 | cell killing(GO:0001906) |
| 0.2 | 1.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.2 | 0.7 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.2 | 0.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.2 | 0.2 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.2 | 1.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 1.4 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.2 | 0.7 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
| 0.2 | 2.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.2 | 0.5 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.2 | 5.8 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 | 3.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.2 | 0.2 | GO:0031669 | cellular response to nutrient levels(GO:0031669) |
| 0.2 | 0.5 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 1.2 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
| 0.2 | 1.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.2 | 1.5 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.2 | 11.4 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.2 | 0.8 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.2 | 0.2 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.2 | 1.3 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.2 | 0.3 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.2 | 8.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.2 | 0.5 | GO:0019563 | alditol catabolic process(GO:0019405) glycerol catabolic process(GO:0019563) |
| 0.2 | 1.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 1.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 | 1.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.2 | 0.3 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 0.8 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 | 1.6 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.2 | 6.7 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.2 | 0.8 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 | 0.5 | GO:0003218 | bundle of His development(GO:0003166) cardiac left ventricle formation(GO:0003218) |
| 0.2 | 0.5 | GO:0043588 | skin development(GO:0043588) |
| 0.2 | 2.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 | 0.6 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 | 0.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.2 | 4.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 | 0.3 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.2 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 0.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.2 | 0.9 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.2 | 0.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 0.9 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 | 3.1 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
| 0.2 | 0.2 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 1.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.2 | 0.9 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.2 | 0.5 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 | 1.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.2 | 2.9 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.2 | 0.9 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.2 | 0.3 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.2 | 1.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.2 | 0.8 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.2 | 0.2 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
| 0.2 | 1.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 | 0.8 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.2 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.1 | 0.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 | 0.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 | 0.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.1 | 1.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.4 | GO:0021934 | medulla oblongata development(GO:0021550) hindbrain tangential cell migration(GO:0021934) |
| 0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 1.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 0.9 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.1 | 1.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 1.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 | 2.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.6 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 | 1.7 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
| 0.1 | 1.0 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 0.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.1 | 1.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.4 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 | 1.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 2.0 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.1 | 0.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.1 | 0.4 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 0.6 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 | 1.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 | 76.6 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 0.4 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.1 | 0.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 0.7 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 | 0.6 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 | 1.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 0.3 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.1 | 0.4 | GO:0098502 | polynucleotide dephosphorylation(GO:0098501) DNA dephosphorylation(GO:0098502) |
| 0.1 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.1 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.1 | 2.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 3.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.3 | GO:0070781 | response to biotin(GO:0070781) |
| 0.1 | 16.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.1 | 2.7 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 1.8 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.7 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.5 | GO:0006569 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 0.1 | 0.4 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.1 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 0.8 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 4.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 1.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 2.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 1.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 1.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.5 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
| 0.1 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 | 1.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 1.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.1 | 0.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 4.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 1.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 5.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 1.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 1.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.5 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.5 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 | 1.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 3.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.6 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.1 | 0.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.1 | 1.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 | 1.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
| 0.1 | 17.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 4.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 0.3 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.1 | 0.9 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.1 | 0.4 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
| 0.1 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.1 | 0.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 | 2.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 | 1.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.4 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.1 | 0.4 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
| 0.1 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.1 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 1.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 0.7 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
| 0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 0.6 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 0.5 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.1 | 1.4 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 | 1.2 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
| 0.1 | 1.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
| 0.1 | 1.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.2 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 | 0.5 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 2.3 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.1 | 3.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 0.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.1 | 1.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 0.6 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 0.3 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 | 2.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.1 | 0.1 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 | 0.3 | GO:1903774 | late endosomal microautophagy(GO:0061738) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 | 0.5 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.1 | 0.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 | 1.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
| 0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
| 0.1 | 0.2 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 | 0.8 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.6 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.1 | 1.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 | 0.3 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.1 | 0.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 1.5 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.1 | 1.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 | 0.4 | GO:0051181 | cofactor transport(GO:0051181) |
| 0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
| 0.1 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.1 | 3.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 | 2.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.1 | 2.5 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.1 | 0.5 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.1 | 1.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 1.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 1.1 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 1.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 | 1.2 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 0.3 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.1 | 0.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 0.3 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.3 | GO:1903452 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.1 | 0.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 0.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.1 | 0.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 | 0.4 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.1 | 1.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.1 | 0.5 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 | 0.5 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 2.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.6 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 0.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 0.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 | 0.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.1 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
| 0.1 | 0.4 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.1 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.4 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.1 | 3.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 0.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.1 | 0.3 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.4 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 | 0.3 | GO:0010878 | cholesterol storage(GO:0010878) |
| 0.1 | 0.3 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 | 0.7 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.1 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 1.9 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 | 0.3 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.1 | 0.5 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 1.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.1 | 0.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 | 6.4 | GO:0030217 | T cell differentiation(GO:0030217) |
| 0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
| 0.1 | 0.3 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.1 | 0.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 | 0.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.4 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.1 | 1.0 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
| 0.1 | 2.9 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 0.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 5.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 1.7 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 2.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.1 | 0.4 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
| 0.1 | 0.8 | GO:0018904 | ether metabolic process(GO:0018904) |
| 0.1 | 0.9 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 | 0.4 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 0.9 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.1 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 0.3 | GO:0016137 | glycoside metabolic process(GO:0016137) |
| 0.1 | 1.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 0.1 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.1 | 0.4 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.1 | 1.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 1.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 0.4 | GO:0046349 | N-acetylglucosamine biosynthetic process(GO:0006045) amino sugar biosynthetic process(GO:0046349) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.1 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 0.7 | GO:1900044 | histone H2A K63-linked ubiquitination(GO:0070535) regulation of protein K63-linked ubiquitination(GO:1900044) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 | 1.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.1 | 1.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.2 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.1 | 0.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 | 1.0 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 0.6 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 | 0.2 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 0.5 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.1 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 1.0 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.1 | 0.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 | 2.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 3.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 0.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 0.2 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.1 | 2.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 | 0.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 4.2 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
| 0.1 | 5.5 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 | 0.8 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.1 | 0.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 2.8 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 | 0.6 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.6 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.2 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.1 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 0.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 2.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 1.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.1 | 0.8 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 | 0.6 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 3.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.1 | 1.0 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.1 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 0.5 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.1 | 0.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 0.5 | GO:0043201 | response to leucine(GO:0043201) |
| 0.1 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 1.1 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
| 0.1 | 0.4 | GO:0010814 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 3.3 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.1 | 0.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 0.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 | 1.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 0.9 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
| 0.1 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.1 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 0.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.8 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.3 | GO:0031018 | endocrine pancreas development(GO:0031018) |
| 0.1 | 0.5 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 0.1 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
| 0.1 | 2.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.1 | 0.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 0.2 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.1 | 1.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 1.7 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
| 0.1 | 1.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.1 | 1.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.1 | GO:0051030 | snRNA export from nucleus(GO:0006408) snRNA transport(GO:0051030) |
| 0.1 | 1.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 0.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 0.5 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
| 0.1 | 0.5 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 0.2 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.1 | 0.2 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
| 0.1 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 1.2 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 1.0 | GO:0071364 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.1 | 0.3 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 | 1.5 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 1.9 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.1 | 8.4 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.1 | 1.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.1 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 | 1.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 2.0 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.8 | GO:0006544 | glycine metabolic process(GO:0006544) |
| 0.1 | 2.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.1 | 0.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 1.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 0.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.1 | 0.8 | GO:0015865 | purine nucleotide transport(GO:0015865) |
| 0.1 | 0.8 | GO:0048821 | erythrocyte development(GO:0048821) |
| 0.1 | 0.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.1 | 1.5 | GO:0061718 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 0.2 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 0.1 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
| 0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.8 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 0.2 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.1 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
| 0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.1 | 0.4 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 1.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.1 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 0.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 | 0.3 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.1 | 0.2 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 | 0.1 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.1 | 0.2 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
| 0.1 | 0.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.1 | 0.2 | GO:0072086 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.1 | 3.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.1 | 0.5 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 | 0.0 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
| 0.0 | 0.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 1.0 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.0 | 0.1 | GO:0051905 | pigment granule localization(GO:0051875) establishment of pigment granule localization(GO:0051905) |
| 0.0 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.0 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 0.0 | 2.3 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.0 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.0 | 0.3 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.0 | 1.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.0 | 0.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.0 | 0.2 | GO:0070894 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.0 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.0 | 0.2 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.0 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 | 1.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
| 0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
| 0.0 | 1.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.2 | GO:0010324 | membrane invagination(GO:0010324) |
| 0.0 | 0.0 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
| 0.0 | 1.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 1.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
| 0.0 | 0.1 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.0 | 0.1 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 | 0.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.0 | 1.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.0 | 0.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
| 0.0 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.7 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.0 | 0.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.0 | 0.4 | GO:0032196 | transposition(GO:0032196) |
| 0.0 | 0.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 | 0.0 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.2 | GO:0071450 | response to superoxide(GO:0000303) response to oxygen radical(GO:0000305) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.0 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 | 0.1 | GO:0060489 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.0 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.0 | 0.1 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.0 | 0.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 | 0.2 | GO:0060324 | face development(GO:0060324) |
| 0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.0 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.0 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 | 0.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.0 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.0 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 1.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 | 0.7 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.0 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.0 | 0.1 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.0 | 1.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.0 | 0.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.0 | 0.1 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.0 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 | 0.5 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
| 0.0 | 0.4 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.0 | 0.0 | GO:0072179 | nephric duct formation(GO:0072179) |
| 0.0 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.0 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 | 0.1 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 | 0.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.0 | 0.2 | GO:0060613 | fat pad development(GO:0060613) |
| 0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.0 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.5 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.1 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
| 0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 0.1 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.0 | 0.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.5 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 | 0.7 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 | 0.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
| 0.0 | 0.2 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.0 | 0.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.0 | 0.3 | GO:0051645 | Golgi localization(GO:0051645) |
| 0.0 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
| 0.0 | 0.1 | GO:0098727 | maintenance of cell number(GO:0098727) |
| 0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.0 | 0.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 | 0.1 | GO:0019079 | viral genome replication(GO:0019079) |
| 0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 | 0.6 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.0 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 1.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.0 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 2.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.1 | GO:2000078 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.0 | 0.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.0 | 0.5 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 | 0.1 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
| 0.0 | 0.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 0.0 | GO:0045837 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
| 0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 2.1 | GO:0006413 | translational initiation(GO:0006413) |
| 0.0 | 0.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.0 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 0.3 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 0.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) asymmetric stem cell division(GO:0098722) |
| 0.0 | 0.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.0 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.0 | 0.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.7 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
| 0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.0 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 | 0.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
| 0.0 | 0.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.0 | 0.2 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.0 | 0.1 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.1 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.0 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.0 | 0.0 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
| 0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
| 0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.0 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.0 | 0.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.0 | 0.0 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.0 | 0.1 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) pulmonary artery morphogenesis(GO:0061156) paramesonephric duct development(GO:0061205) |
| 0.0 | 0.1 | GO:0019748 | secondary metabolic process(GO:0019748) |
| 0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.0 | 0.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
| 0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.0 | 0.0 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 | 0.1 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 | 2.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
| 0.0 | 0.0 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.0 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.0 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.0 | 0.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 | 0.0 | GO:0007067 | mitotic nuclear division(GO:0007067) |
| 0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.0 | 0.5 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.3 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.0 | 0.0 | GO:0080009 | mRNA methylation(GO:0080009) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.6 | 19.9 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 2.2 | 20.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 2.0 | 103.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 1.9 | 5.7 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 1.7 | 22.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.6 | 6.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 1.4 | 2.8 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 1.4 | 4.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 1.3 | 14.8 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 1.3 | 25.3 | GO:0042627 | chylomicron(GO:0042627) |
| 1.1 | 7.9 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 1.1 | 9.0 | GO:0032010 | phagolysosome(GO:0032010) |
| 1.1 | 7.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 1.1 | 3.3 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 1.1 | 9.5 | GO:0044194 | cytolytic granule(GO:0044194) |
| 1.0 | 9.6 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.9 | 4.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.9 | 10.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.9 | 3.6 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.8 | 8.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.8 | 8.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.8 | 18.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.8 | 12.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.7 | 15.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.7 | 2.9 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.7 | 2.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.7 | 3.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.7 | 4.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.7 | 2.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.6 | 5.0 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.6 | 5.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.6 | 8.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 1.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.6 | 3.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.5 | 0.5 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.5 | 1.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.5 | 4.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.5 | 105.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.5 | 33.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.5 | 5.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.5 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.5 | 2.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.5 | 1.5 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.5 | 1.4 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.5 | 4.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 1.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.5 | 1.4 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.4 | 2.2 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.4 | 1.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.4 | 9.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.4 | 1.3 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.4 | 1.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.4 | 7.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.4 | 40.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.4 | 2.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.4 | 9.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.4 | 2.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.4 | 2.4 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.4 | 1.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.4 | 2.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.4 | 3.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.4 | 40.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.4 | 1.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.4 | 7.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.4 | 3.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.4 | 2.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.3 | 2.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.3 | 1.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 36.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.3 | 3.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.3 | 1.3 | GO:0001652 | granular component(GO:0001652) |
| 0.3 | 1.0 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.3 | 1.9 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 0.3 | 2.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 1.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 0.9 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 3.4 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.3 | 6.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.3 | 1.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.3 | 2.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.3 | 0.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.3 | 4.8 | GO:0042599 | lamellar body(GO:0042599) |
| 0.3 | 0.9 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.3 | 8.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.3 | 1.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.3 | 1.2 | GO:0044753 | amphisome(GO:0044753) |
| 0.3 | 1.2 | GO:0043293 | apoptosome(GO:0043293) |
| 0.3 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.3 | 0.9 | GO:0005715 | late recombination nodule(GO:0005715) |
| 0.3 | 1.2 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.3 | 8.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.3 | 4.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 1.4 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.3 | 1.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.3 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.3 | 2.7 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.3 | 0.5 | GO:1990462 | omegasome(GO:1990462) |
| 0.3 | 7.0 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.3 | 1.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 42.5 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.3 | 2.4 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 1.0 | GO:0097183 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.3 | 0.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.3 | 0.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.3 | 2.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 1.0 | GO:0031523 | Myb complex(GO:0031523) |
| 0.3 | 3.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.3 | 0.8 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.3 | 18.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 6.7 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.2 | 1.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 1.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.2 | 1.0 | GO:0097196 | Shu complex(GO:0097196) |
| 0.2 | 1.5 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 1.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 1.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.2 | 7.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.2 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 11.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.2 | 0.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 1.4 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.2 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.2 | 26.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.2 | 3.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 2.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 1.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.2 | 1.6 | GO:0001740 | Barr body(GO:0001740) |
| 0.2 | 1.8 | GO:0031415 | NatA complex(GO:0031415) |
| 0.2 | 0.9 | GO:0030496 | midbody(GO:0030496) |
| 0.2 | 0.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.2 | 1.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 1.7 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.2 | 6.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 6.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.2 | 5.9 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.2 | 2.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 2.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 2.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 0.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.2 | 0.6 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.2 | 0.4 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.2 | 1.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 1.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 3.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 0.4 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.2 | 1.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.2 | 1.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.2 | 2.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 1.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.2 | 27.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.2 | 1.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.2 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 0.9 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 1.1 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.2 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.2 | 7.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.2 | 10.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 0.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.2 | 0.5 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.2 | 10.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.2 | 1.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.2 | 18.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.2 | 29.2 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 2.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.2 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.2 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.2 | 2.7 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 0.5 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.2 | 2.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 2.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 0.2 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.2 | 0.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.2 | 2.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 12.0 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 1.1 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 1.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 0.3 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 0.1 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 44.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 1.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 2.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 3.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 1.2 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 1.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
| 0.1 | 20.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 2.9 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 2.8 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 2.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 2.1 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 1.1 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 1.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 0.4 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 1.6 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.4 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 0.1 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 2.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 0.4 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 1.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.1 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 2.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.4 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.1 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 5.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 1.0 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.1 | 13.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 2.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 0.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 17.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.1 | 1.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 1.8 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 0.6 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 0.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 0.5 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.1 | 1.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 3.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 0.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 2.1 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 0.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 1.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 8.0 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.1 | 0.5 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 1.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 1.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.1 | 1.5 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 1.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 1.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.1 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 0.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.1 | 22.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 5.8 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 0.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
| 0.1 | 0.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 12.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 10.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 1.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.4 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.1 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 1.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 14.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.1 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 1.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 2.6 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.1 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.1 | 2.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.1 | 0.7 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.2 | GO:0034448 | EGO complex(GO:0034448) |
| 0.1 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 0.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 0.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 35.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 2.7 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 0.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 4.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 0.8 | GO:0005767 | secondary lysosome(GO:0005767) |
| 0.1 | 0.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 0.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.3 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.1 | 6.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.1 | 0.5 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
| 0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 1.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 1.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 3.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 0.4 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 3.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 0.7 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.1 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 10.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.1 | 0.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.1 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.1 | 1.4 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 4.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.1 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 1.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 1.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 5.1 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.1 | 0.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 19.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
| 0.1 | 2.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.1 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.5 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 1.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 0.2 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 0.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.0 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.0 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.0 | 4.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.0 | 2.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 1.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 15.9 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 15.0 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.0 | 1.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
| 0.0 | 4.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.0 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 3.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.0 | 1.8 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.0 | 1.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 26.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 0.8 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.2 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
| 0.0 | 0.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 2.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.0 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.0 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.0 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 0.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.0 | 5.8 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.0 | 0.1 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
| 0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
| 0.0 | 0.5 | GO:0030141 | secretory granule(GO:0030141) |
| 0.0 | 7.3 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 0.0 | GO:0043203 | axon hillock(GO:0043203) |
| 0.0 | 0.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.0 | 0.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 0.0 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.0 | GO:0043219 | lateral loop(GO:0043219) |
| 0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
| 0.0 | 1.2 | GO:0005635 | nuclear envelope(GO:0005635) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 16.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 3.5 | 3.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 2.5 | 2.5 | GO:0035473 | lipase binding(GO:0035473) |
| 2.5 | 7.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 2.4 | 16.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 2.4 | 7.1 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 2.2 | 9.0 | GO:0019862 | IgA binding(GO:0019862) |
| 2.1 | 10.3 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 2.0 | 8.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 2.0 | 17.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 1.9 | 123.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 1.8 | 7.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 1.7 | 10.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 1.6 | 11.4 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 1.6 | 6.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 1.5 | 6.2 | GO:0017129 | triglyceride binding(GO:0017129) |
| 1.5 | 10.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.5 | 4.5 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 1.5 | 5.9 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 1.4 | 4.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 1.4 | 5.7 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 1.4 | 5.7 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 1.4 | 16.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 1.4 | 11.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 1.4 | 1.4 | GO:0008430 | selenium binding(GO:0008430) |
| 1.3 | 4.0 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 1.3 | 2.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.3 | 6.4 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 1.3 | 5.1 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 1.3 | 1.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 1.3 | 5.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 1.2 | 3.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.2 | 4.9 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 1.2 | 2.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 1.2 | 4.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 1.2 | 6.0 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 1.2 | 3.5 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 1.1 | 11.4 | GO:0005497 | androgen binding(GO:0005497) |
| 1.1 | 3.4 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 1.1 | 6.7 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 1.1 | 3.3 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 1.1 | 13.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.1 | 4.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 1.1 | 5.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.0 | 2.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 1.0 | 7.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.0 | 6.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 1.0 | 2.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.0 | 2.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 1.0 | 3.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 1.0 | 200.5 | GO:0003823 | antigen binding(GO:0003823) |
| 1.0 | 2.9 | GO:0001847 | opsonin receptor activity(GO:0001847) complement component C5a receptor activity(GO:0004878) |
| 1.0 | 3.8 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.9 | 3.8 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.9 | 5.7 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.9 | 7.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.9 | 4.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.9 | 2.7 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.9 | 1.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.9 | 3.6 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.9 | 1.8 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.9 | 6.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.8 | 13.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.8 | 2.5 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.8 | 1.7 | GO:0034618 | arginine binding(GO:0034618) |
| 0.8 | 2.5 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.8 | 8.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.8 | 3.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.8 | 2.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.8 | 3.2 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.8 | 2.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.8 | 6.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.8 | 2.3 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.8 | 2.3 | GO:0052853 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.8 | 2.3 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.8 | 2.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.7 | 5.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.7 | 2.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.7 | 11.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.7 | 2.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.7 | 2.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.7 | 2.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.7 | 2.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.7 | 2.7 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.7 | 2.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.7 | 4.6 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.6 | 2.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.6 | 2.6 | GO:0004803 | transposase activity(GO:0004803) |
| 0.6 | 3.8 | GO:0070905 | serine binding(GO:0070905) |
| 0.6 | 5.0 | GO:0046790 | virion binding(GO:0046790) |
| 0.6 | 1.9 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.6 | 1.9 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.6 | 4.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.6 | 2.5 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 0.6 | 13.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.6 | 1.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.6 | 1.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.6 | 11.6 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.6 | 6.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.6 | 3.7 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
| 0.6 | 1.8 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
| 0.6 | 3.6 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.6 | 4.2 | GO:0042806 | fucose binding(GO:0042806) |
| 0.6 | 2.4 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.6 | 7.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.6 | 21.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.6 | 1.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.6 | 2.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.6 | 2.3 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.6 | 10.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.6 | 3.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.6 | 2.3 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.6 | 1.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.6 | 2.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.6 | 1.7 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.6 | 1.7 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.6 | 3.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.5 | 4.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.5 | 1.6 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.5 | 2.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.5 | 2.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.5 | 7.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.5 | 1.6 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.5 | 1.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.5 | 2.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.5 | 2.7 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.5 | 7.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.5 | 3.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.5 | 3.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.5 | 2.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.5 | 2.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.5 | 11.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.5 | 8.7 | GO:0005537 | mannose binding(GO:0005537) |
| 0.5 | 2.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.5 | 7.1 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.5 | 2.5 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.5 | 2.5 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.5 | 3.5 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.5 | 1.5 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.5 | 15.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.5 | 2.0 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.5 | 4.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.5 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.5 | 1.4 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.5 | 3.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.5 | 9.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.5 | 0.5 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.5 | 1.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.5 | 1.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.5 | 1.4 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.5 | 4.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.5 | 0.9 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.5 | 4.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.5 | 1.4 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.5 | 1.4 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.4 | 2.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.4 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.4 | 2.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.4 | 5.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.4 | 1.3 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.4 | 1.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.4 | 1.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.4 | 2.2 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.4 | 1.7 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.4 | 2.6 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.4 | 2.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.4 | 1.3 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.4 | 6.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.4 | 1.3 | GO:0005534 | galactose binding(GO:0005534) |
| 0.4 | 1.7 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.4 | 1.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.4 | 1.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.4 | 3.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.4 | 5.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.4 | 2.9 | GO:0019863 | IgE binding(GO:0019863) |
| 0.4 | 44.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.4 | 1.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.4 | 0.8 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.4 | 4.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.4 | 1.6 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.4 | 6.0 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.4 | 10.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.4 | 2.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.4 | 1.2 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.4 | 5.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.4 | 1.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.4 | 9.9 | GO:0001848 | complement binding(GO:0001848) |
| 0.4 | 2.4 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.4 | 1.2 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.4 | 1.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.4 | 2.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.4 | 3.5 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.4 | 1.2 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.4 | 1.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.4 | 0.8 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.4 | 1.2 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.4 | 1.1 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.4 | 3.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.4 | 1.9 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.4 | 0.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.4 | 2.6 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.4 | 1.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.4 | 1.1 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.4 | 1.5 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.4 | 2.6 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.4 | 1.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
| 0.4 | 1.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.4 | 0.7 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.4 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.4 | 5.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.4 | 6.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.4 | 3.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.4 | 4.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.4 | 1.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.4 | 6.4 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.4 | 19.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.4 | 0.7 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.4 | 1.8 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 7.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.3 | 0.7 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 6.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.3 | 1.7 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.3 | 1.0 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.3 | 1.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.3 | 8.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 2.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.3 | 1.4 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.3 | 0.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.3 | 54.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 0.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.3 | 4.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 0.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.3 | 0.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.3 | 1.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 1.9 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.3 | 8.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.3 | 1.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.3 | 4.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.3 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.3 | 1.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.3 | 1.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
| 0.3 | 3.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 4.1 | GO:0019864 | IgG binding(GO:0019864) |
| 0.3 | 14.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.3 | 1.3 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.3 | 2.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.3 | 0.6 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.3 | 5.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.3 | 6.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.3 | 6.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.3 | 2.5 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.3 | 4.0 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.3 | 4.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.3 | 1.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.3 | 0.9 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.3 | 1.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.3 | 1.2 | GO:0004325 | ferrochelatase activity(GO:0004325) |
| 0.3 | 3.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.3 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.3 | 2.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.3 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.3 | 1.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.3 | 8.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 0.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.3 | 2.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.3 | 0.9 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.3 | 2.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.3 | 2.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.3 | 4.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.3 | 15.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.3 | 7.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.3 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.3 | 2.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.3 | 1.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.3 | 0.9 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.3 | 2.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.3 | 1.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 0.8 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.3 | 12.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.3 | 0.8 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.3 | 2.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.3 | 1.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.3 | 3.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.3 | 0.3 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.3 | 2.5 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 1.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 1.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.3 | 3.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.3 | 1.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.3 | 1.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.3 | 0.3 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.3 | 2.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.3 | 1.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.3 | 1.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.3 | 3.2 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.3 | 0.3 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
| 0.3 | 1.9 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.3 | 0.8 | GO:0055100 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
| 0.3 | 3.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.3 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.3 | 3.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.3 | 1.0 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.3 | 2.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.3 | 0.5 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
| 0.3 | 1.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.3 | 1.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.3 | 1.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.3 | 1.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.3 | 2.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 1.0 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.3 | 1.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.2 | 3.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.2 | 21.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.2 | 0.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.2 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 0.7 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.2 | 4.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.2 | 7.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 2.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 2.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.2 | 1.7 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
| 0.2 | 7.8 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 0.2 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.2 | 0.7 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.2 | 0.7 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.2 | 0.7 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.2 | 0.7 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.2 | 2.1 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.2 | 0.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 1.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 1.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.2 | 0.9 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.2 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.2 | 1.8 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.2 | 0.7 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.2 | 0.9 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.2 | 0.7 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.2 | 1.1 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.2 | 0.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.2 | 0.9 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.2 | 2.9 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.2 | 0.7 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.2 | 1.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.2 | 0.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.2 | 0.7 | GO:0047017 | geranylgeranyl reductase activity(GO:0045550) prostaglandin-F synthase activity(GO:0047017) |
| 0.2 | 1.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.2 | 5.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 0.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.2 | 1.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.2 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.2 | 2.6 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.2 | 1.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.2 | 2.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.2 | 6.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 3.6 | GO:0071949 | FAD binding(GO:0071949) |
| 0.2 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 3.6 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 0.8 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.2 | 0.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.2 | 1.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 1.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.2 | 0.8 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.2 | 3.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.2 | 4.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 3.5 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 25.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 0.2 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.2 | 0.6 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 0.2 | 1.8 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 0.8 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.2 | 0.6 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.2 | 6.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.2 | 3.0 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.2 | 1.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.2 | 0.6 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.2 | 0.8 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.2 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.2 | 1.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 0.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.2 | 0.4 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.2 | 2.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.2 | 0.8 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.2 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 2.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.2 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 4.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.2 | 1.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.2 | 0.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.2 | 2.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.2 | 4.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.2 | 0.6 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.2 | 0.6 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.2 | 6.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 2.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 0.7 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.2 | 1.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.2 | 2.2 | GO:0060229 | lipase activator activity(GO:0060229) |
| 0.2 | 2.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 0.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.2 | 0.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 1.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.2 | 2.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.2 | 3.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.2 | 2.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 1.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.2 | 0.4 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 4.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.2 | 1.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 4.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 1.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.2 | 4.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.2 | 1.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.2 | 4.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 0.5 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 0.7 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.2 | 2.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.2 | 9.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 0.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 1.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.2 | 0.8 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.2 | 2.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 0.2 | 2.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 0.5 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.2 | 1.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 1.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.2 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.2 | 4.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 1.0 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.2 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.2 | 0.5 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 0.3 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.2 | 0.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.2 | 3.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 1.0 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.2 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.2 | 2.6 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.2 | 4.3 | GO:0016208 | AMP binding(GO:0016208) |
| 0.2 | 0.3 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.2 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.2 | 1.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.2 | 4.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.2 | 1.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.2 | 0.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.2 | 0.5 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.2 | 0.6 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.2 | 4.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 0.9 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.2 | 0.9 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.2 | 0.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 1.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.2 | 0.8 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.2 | 6.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 6.5 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.2 | 3.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.2 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 2.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.1 | 2.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 0.4 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.1 | 0.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.1 | 1.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 1.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 0.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 0.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.1 | 13.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.1 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.1 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.6 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
| 0.1 | 0.3 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 0.4 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
| 0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.1 | 34.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 3.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.1 | 0.6 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.1 | 1.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 1.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 4.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 0.7 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.1 | 0.8 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.1 | 1.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 0.1 | 0.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.1 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 2.4 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 3.9 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 5.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 1.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.1 | 2.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.5 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.1 | 0.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.1 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 0.4 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.1 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 0.5 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.1 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.4 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.1 | 2.6 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 3.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.4 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.1 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 1.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.1 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 5.4 | GO:0043531 | ADP binding(GO:0043531) |
| 0.1 | 13.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.1 | 0.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.1 | 1.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.1 | 1.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 2.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 4.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 1.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.1 | 3.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 5.3 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 1.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.1 | 2.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 1.0 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 0.3 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.1 | 1.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 0.1 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.1 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 0.2 | GO:0016653 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
| 0.1 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.1 | 0.7 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 0.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.3 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.1 | 4.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 1.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 0.5 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.1 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 1.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.3 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.1 | 0.4 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 0.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 2.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 0.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 3.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 0.1 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 0.1 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.1 | 2.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 2.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 3.0 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.6 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.1 | 0.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 0.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 9.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 0.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.1 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 1.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
| 0.1 | 8.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.1 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.1 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.3 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.1 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 1.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.1 | 1.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 2.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 1.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.1 | 0.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 7.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.1 | 1.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 0.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.1 | 3.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.1 | 5.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.1 | 1.4 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.1 | 0.2 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.1 | 0.5 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.1 | 0.3 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.7 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 0.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.1 | 0.8 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.1 | 0.7 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 1.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 1.0 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.1 | 2.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 2.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.1 | 0.4 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 2.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 1.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.2 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.1 | 2.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.1 | 1.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 3.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.2 | GO:0047696 | G-protein coupled receptor kinase activity(GO:0004703) beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 3.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 3.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 1.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.1 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 0.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 1.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 0.2 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.1 | 1.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.1 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 5.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.1 | 0.6 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.1 | 1.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 7.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.1 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.2 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.1 | 0.8 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.1 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.1 | 2.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.2 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.1 | 0.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 14.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 13.1 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 4.9 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) pre-miRNA transporter activity(GO:0090631) |
| 0.1 | 0.2 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.1 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 4.4 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.1 | 1.1 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.1 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 4.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 3.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
| 0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
| 0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.1 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 0.1 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.1 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 1.0 | GO:0044877 | macromolecular complex binding(GO:0044877) |
| 0.1 | 1.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.5 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 0.5 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
| 0.1 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.0 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.0 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.0 | 1.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.0 | 0.0 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 0.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.0 | 0.1 | GO:0042562 | hormone binding(GO:0042562) |
| 0.0 | 0.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.0 | 0.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.0 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.0 | 14.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 1.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.0 | 0.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.5 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
| 0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.0 | 3.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.0 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.0 | 0.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.0 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.0 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.0 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 2.6 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.1 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.0 | 0.8 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 0.3 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.0 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.0 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.0 | 0.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.0 | 0.1 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.0 | 0.1 | GO:0032451 | demethylase activity(GO:0032451) |
| 0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.0 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.0 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 1.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.2 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.0 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.0 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.0 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.0 | 0.2 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
| 0.0 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.0 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
| 0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 0.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.0 | 4.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.3 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.0 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.1 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.0 | 1.5 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.0 | 0.1 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.0 | 0.6 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.1 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.0 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 1.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.2 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.0 | 0.1 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.0 | 1.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.0 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.0 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.0 | 1.8 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.0 | 1.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.0 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.1 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.0 | 1.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.0 | 0.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.0 | 3.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.0 | 0.0 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.0 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.0 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.1 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.0 | 3.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.0 | GO:0052866 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
| 0.0 | 0.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) thyroid hormone receptor activity(GO:0004887) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.4 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.0 | 0.5 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 2.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 1.1 | 2.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 1.1 | 5.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.9 | 3.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.9 | 27.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.8 | 58.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.7 | 6.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.6 | 4.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.6 | 6.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.6 | 63.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.5 | 20.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.5 | 23.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.5 | 4.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.4 | 15.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.4 | 9.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.4 | 42.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.4 | 0.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.4 | 14.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.4 | 29.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.4 | 12.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 29.5 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.3 | 8.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 18.9 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.3 | 11.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.3 | 24.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.3 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.3 | 16.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.3 | 10.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 3.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.3 | 2.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.3 | 5.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.3 | 13.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 6.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 21.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 1.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.2 | 1.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 5.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 8.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 2.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.2 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.2 | 2.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 4.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 2.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 3.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 2.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 5.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.2 | 9.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.2 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.2 | 4.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 6.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.2 | 10.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 2.2 | PID FOXO PATHWAY | FoxO family signaling |
| 0.2 | 4.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 3.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 7.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 3.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 3.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 13.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 4.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 3.7 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 5.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 2.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 4.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 5.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 0.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 6.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 7.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 2.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 1.7 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 34.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 1.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 10.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 7.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 1.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 9.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 6.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 4.0 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 6.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 3.6 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 2.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 2.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 1.8 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 1.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 0.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 36.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 1.4 | 25.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 1.4 | 36.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 1.1 | 33.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.8 | 23.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.8 | 96.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.7 | 19.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.7 | 9.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.6 | 7.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.6 | 2.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.6 | 7.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.6 | 19.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.6 | 21.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.6 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.6 | 10.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.5 | 8.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.5 | 10.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.4 | 26.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.4 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.4 | 9.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.4 | 13.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.4 | 1.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.4 | 7.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.4 | 28.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.4 | 11.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.4 | 9.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.4 | 10.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.4 | 4.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.3 | 9.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.3 | 12.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 9.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.3 | 5.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.3 | 29.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.3 | 8.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.3 | 31.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.3 | 8.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.3 | 4.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.3 | 1.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 3.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 2.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.3 | 0.6 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.3 | 6.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.3 | 8.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.3 | 4.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.3 | 9.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.3 | 2.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.3 | 6.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.3 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.3 | 12.9 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.3 | 2.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.3 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 2.5 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
| 0.2 | 8.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 2.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.2 | 2.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 12.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.2 | 3.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 4.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.2 | 10.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 14.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 1.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.2 | 5.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 4.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 5.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 8.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.2 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.2 | 12.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 5.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.2 | 2.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.2 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 5.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 21.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.2 | 3.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.2 | 2.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.2 | 2.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 5.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 4.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 0.7 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.2 | 5.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.2 | 5.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.2 | 4.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 5.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 3.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.2 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.2 | 3.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.2 | 7.5 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.2 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 9.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.2 | 0.6 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.2 | 3.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.2 | 2.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 3.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 14.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.1 | 12.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 11.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 3.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 2.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 22.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 2.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 2.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.1 | 21.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 5.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 6.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 2.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 5.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 0.1 | 4.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 14.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 2.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 4.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.1 | 0.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.1 | 3.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 0.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.1 | 5.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 5.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 3.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 4.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 6.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 12.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 2.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 7.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 2.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 5.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.1 | 7.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 9.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 1.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 2.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 1.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.1 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 3.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 0.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 2.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 1.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
| 0.1 | 0.7 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 3.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 3.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.1 | 1.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 2.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 2.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.1 | 2.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 4.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.1 | 1.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 2.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 6.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 4.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 1.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 7.6 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 2.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 0.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 2.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 1.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 7.7 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 1.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 2.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 2.6 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.0 | 2.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.0 | 0.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 1.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 2.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.8 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
| 0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 2.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 2.7 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
| 0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |